From the Wrexham Maelor Hospital (X.T.L., E.A., Z.X.L.), Betsi Cadwaladr University Health Board, Wrexham; Department of General Surgery (Shahin.H.), Sandwell and West Birmingham Hospitals NHS Trust, Birmingham; and Department of General Surgery (Shahab.H.), Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl, United Kingdom.
J Trauma Acute Care Surg. 2021 Jan 1;90(1):191-201. doi: 10.1097/TA.0000000000002976.
Traumatic brain injury (TBI) is a leading cause of injury-related deaths and neurological disability globally. Considering the widespread anticoagulant use among the aging population, we aimed to perform a systematic review and meta-analysis to evaluate the prognostic significance of preinjury anticoagulation in TBI patients.
This systematic review was conducted according to a predefined protocol (International Prospective Register of Systematic Reviews CRD42020192323). In compliance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analysis of Observational Studies in Epidemiology standards, a structured electronic database search was undertaken to identify all observational studies comparing preinjury anticoagulation with no preinjury anticoagulation in TBI patients. The primary outcome measure was overall mortality. The secondary outcome measures comprised in-hospital mortality, length of hospital stay, length of intensive care unit stay, need for neurosurgical procedure, and number of patients discharged home. All outcome data were analyzed using random effects modeling.
Twelve comparative studies enrolling a total of 4,417 patients were included. Preinjury anticoagulation was associated with higher risk of overall mortality (odds ratio [OR], 2.39; 95% confidence interval [CI], 1.63-3.50, p < 0.00001), in-hospital mortality (OR, 2.47; 95% CI, 1.56-3.93, p = 0.0001), and longer length of intensive care unit stay (mean difference, 1.06; 95% CI, 0.54-1.57; p < 0.0001) compared with no preinjury anticoagulation. No statistical difference was observed in length of hospital stay (mean difference, -2.15; 95% CI, -5.36 to 1.05, p = 0.19), need for neurosurgical procedure (OR, 1.30; 95% CI, 0.70-2.44; p = 0.41), and discharged home (OR, 0.76; 95% CI, 0.55-1.04; p = 0.09) between the two groups.
Preinjury anticoagulation is a powerful prognosticator of mortality in TBI patients. This highlights the need for dedicated triage and trauma team activation protocols considering earlier intervention and more aggressive imaging in all anticoagulated patients. Future studies should focus on strategies that can potentially reduce the risk of mortality in this population. The prognostic significance of direct oral anticoagulants versus warfarin remains unanswered.
Systematic review and meta-analysis of observational studies, level III.
创伤性脑损伤(TBI)是全球导致伤后死亡和神经功能残疾的主要原因。考虑到老龄化人群中广泛使用抗凝剂,我们旨在进行系统评价和荟萃分析,以评估 TBI 患者受伤前抗凝的预后意义。
本系统评价按照预先制定的方案(国际前瞻性注册系统评价 CRD42020192323)进行。根据系统评价和荟萃分析的首选报告项目以及观察性研究荟萃分析的标准,进行了结构化电子数据库搜索,以确定所有比较 TBI 患者受伤前抗凝与无受伤前抗凝的观察性研究。主要结局指标为总体死亡率。次要结局指标包括住院死亡率、住院时间、重症监护病房住院时间、需要神经外科手术以及出院回家的患者人数。所有结局数据均采用随机效应模型进行分析。
共纳入 12 项比较研究,总计纳入 4417 例患者。受伤前抗凝与总体死亡率(优势比 [OR],2.39;95%置信区间 [CI],1.63-3.50,p<0.00001)、住院死亡率(OR,2.47;95%CI,1.56-3.93,p=0.0001)和重症监护病房住院时间延长(平均差异,1.06;95%CI,0.54-1.57;p<0.0001)相关。与无受伤前抗凝相比,两组间住院时间(平均差异,-2.15;95%CI,-5.36 至 1.05,p=0.19)、需要神经外科手术(OR,1.30;95%CI,0.70-2.44;p=0.41)和出院回家(OR,0.76;95%CI,0.55-1.04;p=0.09)无统计学差异。
受伤前抗凝是 TBI 患者死亡率的有力预测因素。这突显了需要专门的分诊和创伤小组激活方案,以考虑在所有抗凝患者中更早的干预和更积极的影像学检查。未来的研究应集中于可能降低该人群死亡率的策略。直接口服抗凝剂与华法林的预后意义仍未得到解答。
观察性研究的系统评价和荟萃分析,III 级。